Area of research
Pediatrics, Perinatology and Child Health · Hematology
Research interest
Research interests include Childhood Cancer Survivors' Quality of Life, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, and Renal and related cancers.
Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature
A comprehensive overview of liquid biopsy applications in pediatric solid tumors
Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study
Increased risk of subsequent neoplasm after hematopoietic stem cell transplantation in 5-year survivors of childhood acute lymphoblastic leukemia
Risk and Protective Factors of Psychosocial Functioning in Survivors of Childhood Cancer: Results of the DCCSS‐LATER Study
The impact of clinically relevant health conditions on psychosocial outcomes in survivors of childhood cancer: results of the DCCSS-LATER study
Outcome after treatment with axitinib in children, young adults, and adults with renal cell carcinoma: a narrative review
Different subtypes of chronic fatigue in childhood cancer survivors: A DCCSS LATER study
Comprehensive molecular and clinical characterization of <i>NUP98</i> fusions in pediatric acute myeloid leukemia
Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm
Cognitive and Behavioral Development of 9-Year-Old Children After Maternal Cancer During Pregnancy: A Prospective Multicenter Cohort Study
Hallmark discoveries in the biology of Wilms tumour
Extensive Cardiac Function Analyses Using Contemporary Echocardiography in Childhood Cancer Survivors
Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study
Radiologic versus Segmentation Measurements to Quantify Wilms Tumor Volume on MRI in Pediatric Patients
Chronic fatigue in childhood cancer survivors is associated with lifestyle and psychosocial factors; a DCCSS LATER study
Positive and negative survivor-specific psychosocial consequences of childhood cancer: the DCCSS-LATER 2 psycho-oncology study
Targeted therapies in children with renal cell carcinoma (<scp>RCC</scp>): An International Society of Pediatric Oncology—Renal Tumor Study Group (<scp>SIOP‐RTSG</scp>)‐related retrospective descriptive study
The impact of the temporal sequence of cranial radiotherapy and platin‐based chemotherapy on hearing impairment in pediatric and adolescent <scp>CNS</scp> and <scp>head‐and‐neck</scp> cancer patients: A report from the <scp>PanCareLIFE</scp> consortium
Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS‐LATER study
Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms
Renal cell carcinoma in children and adolescents: a retrospective study of a French–Italian series of 93 cases
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Somatic mutations and single-cell transcriptomes reveal the root of malignant rhabdoid tumours
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group
Single cell derived mRNA signals across human kidney tumors
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial